Kiniksa Pharmaceuticals International, plc Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $10.70M.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, employee stock purchase plan for fiscal 2025 was $33.02M, a 169.23% increase from fiscal 2024.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, employee stock purchase plan for fiscal 2024 was $12.27M, a 720.47% increase from fiscal 2023.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, employee stock purchase plan for fiscal 2023 was $1.50M, a 40.65% decline from fiscal 2022.
- Kiniksa Pharmaceuticals International, plc stock issued during period, value, employee stock purchase plan for fiscal 2022 was $2.52M.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2025-12-31 | $33.02M 10-K · filed 2026-02-24 | |
| 2025-06-30 | $10.70M 10-Q · filed 2025-10-28 | |
| 2024-12-31 | $12.27M 10-K · filed 2026-02-24 | |
| 2023-12-31 | $1.50M 10-K · filed 2026-02-24 | |
| 2022-12-31 | $2.52M 10-K · filed 2025-02-25 |